|
Olaparib combined with abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A randomized phase II trial. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bayer; Pfizer |
Consulting or Advisory Role - Ipsen; Roche |
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer |
|
|
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer |
|
|
Research Funding - AstraZeneca |
Travel, Accommodations, Expenses - Merck |
|
|
Travel, Accommodations, Expenses - Sanofi |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim |
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi |
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst) |